Mepilex^® Border Heel features proprietary Deep Defense^® technology, providing an optimal balance of strength and flexibility. Each of the unique five layers serves a specific purpose in pressure ulcer prevention adding to the dressing's strength, durability and absorbency.   No other dressing on the market exhibits these same properties – or the published, peer-reviewed results – in pressure ulcer prevention. 

Only Mepilex Border dressings have over 80 evidence pieces to support their effectiveness in preventing pressure ulcers.   The effectiveness of Mepilex Border Heel is supported by several clinical studies, including a study of critically ill patients by Santamaria et al that showed zero pressure ulcers among the intervention cohort of 150 patients receiving Mepilex Border Heel dressings vs. 19 heel pressure ulcers for patients with no heel dressings. 

When used for management of wounds, Mepilex Border Heel effectively absorbs and retains exudate   and maintains a moist wound environment. The Safetac technology layer seals the wound edges, prevents exudate leakage onto the surrounding skin, thus minimizing the risk of maceration.   The Safetac technology layer allows the dressing to be changed without damaging the wound or surrounding skin,   or exposing the patient to additional pain.  

• Mepilex Border dressings proven to prevent pressure ulcers – by up to 88% – when used with other standard prevention protocols    
• Proprietary Deep Defense Technology™ addresses the key factors responsible for pressure ulcers, protecting against the extrinsic forces of pressure, shear and friction and managing microclimate  
• Safetac technology reduces the risk of maceration   and minimizes pain during dressing changes  
• Excellent fluid-handling capacity and retention